Highlights Zhejiang Orient Gene Biotech Co.,Ltd

Equities

688298

CNE100003RM8

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-21 EDT			5-day change	1st Jan Change
29.76 ^CNY	+0.37%		-5.10%	-16.78%

05-16	Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors	MT
04-29	Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products	04-23	MT
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Zhejiang Orient Gene Biotech Co.,Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	02-07	CI
Zhejiang Orient Gene Biotech Co.,Ltd authorizes a Buyback Plan.	02-06	CI
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration	22-11-25	AN
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Omega Diagnostics Up 16% With Sale Of Loss-Making CD4 Business	22-08-03	MT
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
Omega Diagnostics Shares Plunge on $1.4 Million Sale of Loss-making Business to Chinese Biotech	22-02-11	MT
MSCI to Add Gree, Three Gorges Renewables, Others to China Indices	22-02-10	MT
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
An unknown buyer acquired 6.14% stake in Zhejiang Orient Gene Biotech Co., Ltd. from a Shareholder.	21-07-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zhejiang Orient Gene Biotech Co.,Ltd

Equities

688298

CNE100003RM8

Highlights

Filters